The Clorox Company $CLX Shares Bought by Cetera Investment Advisers

Cetera Investment Advisers raised its stake in shares of The Clorox Company (NYSE:CLX) by 44.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 105,704 shares of the company’s stock after purchasing an additional 32,539 shares during the period. Cetera Investment Advisers’ holdings in Clorox were worth $10,954,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Wilkins Investment Counsel Inc. lifted its stake in shares of Clorox by 250.6% in the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after purchasing an additional 39,360 shares during the last quarter. Morningstar Investment Management LLC increased its position in Clorox by 131.8% during the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after buying an additional 35,506 shares during the last quarter. National Pension Service increased its position in Clorox by 68.9% during the fourth quarter. National Pension Service now owns 27,537 shares of the company’s stock worth $2,777,000 after buying an additional 11,233 shares during the last quarter. Birch Hill Investment Advisors LLC bought a new position in Clorox during the fourth quarter valued at about $22,103,000. Finally, Ilmarinen Mutual Pension Insurance Co acquired a new stake in shares of Clorox in the fourth quarter worth about $1,966,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CLX shares. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $94.00 target price on shares of Clorox in a report on Wednesday, July 22nd. Jefferies Financial Group cut Clorox from a “buy” rating to a “hold” rating and decreased their target price for the stock from $125.00 to $98.00 in a research report on Tuesday. Barclays increased their price target on Clorox from $85.00 to $86.00 and gave the company an “underweight” rating in a report on Tuesday, July 21st. Finally, JPMorgan Chase & Co. dropped their price target on shares of Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a research report on Thursday, July 16th. Twelve research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $101.00.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Clorox Price Performance

NYSE CLX opened at $96.69 on Friday. The stock has a 50-day simple moving average of $95.49 and a 200 day simple moving average of $103.72. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $128.90. The stock has a market capitalization of $11.69 billion, a PE ratio of 15.70 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. Research analysts anticipate that The Clorox Company will post 5.52 EPS for the current year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.